As the global artificial intelligence boom places unprecedented strain on computing capacity and hardware availability, chip giant Nvidia has thrown its weight behind Bengaluru-based startup Simplismart. The company has secured $14 million in a Series B funding round, betting heavily on software designed to help corporations run AI models more efficiently, sustainably, and, in many […]
Fusion energy startup Helion has been awarded $175 million in federal funding to research, develop, and manufacture advanced semiconductors and power electronics destined for its commercial fusion power plants, the company announced on Thursday. The three-year award was granted by the Department of Commerce under the CHIPS Act, a bipartisan legislative framework designed to bolster […]
TechCrunch Disrupt 2026 has officially drawn to a close, having spent three electrifying days showcasing the immense talent, cutting-edge ingenuity, and relentless drive of the 2026 Startup Battlefield 200 cohort. Out of thousands of rigorous applications submitted from across the globe, the editorial and curation teams meticulously selected 200 of the most promising early-stage startups. […]
The artificial intelligence boom has fundamentally rewritten the rules of startup velocity. Today’s newly minted enterprises can scale at a breathtaking pace, accumulating eye-popping annual recurring revenue (ARR) figures within months of inception, only to experience catastrophic crashes shortly thereafter. At this year’s TechCrunch Disrupt conference, industry leaders gathered to dissect this phenomenon. Luke Arno, […]
Securing initial customers remains one of the most grueling and high-stakes challenges in the entire lifecycle of a business. Even when young companies manage to generate early buzz, capture initial interest, or secure their first wave of users, there is never a guarantee that those customers will stick around for the long haul. Building lasting […]
For decades, the pharmaceutical industry has relied heavily on animal models to test the safety and efficacy of emerging therapeutics. Yet, fundamental biological differences between species mean that a drug performing successfully in a mouse or a larger animal frequently fails when translated to human clinical trials. Most pharmaceutical candidates still ultimately fail during development, […]